These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 31060435)
1. Global brain volume reductions in a sub-chronic phencyclidine animal model for schizophrenia and their relationship to recognition memory. Doostdar N; Kim E; Grayson B; Harte MK; Neill JC; Vernon AC J Psychopharmacol; 2019 Oct; 33(10):1274-1287. PubMed ID: 31060435 [TBL] [Abstract][Full Text] [Related]
2. Neonatal phencyclidine administration and post-weaning social isolation as a dual-hit model of 'schizophrenia-like' behaviour in the rat. Gaskin PL; Alexander SP; Fone KC Psychopharmacology (Berl); 2014 Jun; 231(12):2533-45. PubMed ID: 24402141 [TBL] [Abstract][Full Text] [Related]
3. Investigating the long-term effect of subchronic phencyclidine-treatment on novel object recognition and the association between the gut microbiota and behavior in the animal model of schizophrenia. Pyndt Jørgensen B; Krych L; Pedersen TB; Plath N; Redrobe JP; Hansen AK; Nielsen DS; Pedersen CS; Larsen C; Sørensen DB Physiol Behav; 2015 Mar; 141():32-9. PubMed ID: 25545766 [TBL] [Abstract][Full Text] [Related]
4. Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: implications for therapy of cognitive dysfunction in schizophrenia. McLean SL; Grayson B; Idris NF; Lesage AS; Pemberton DJ; Mackie C; Neill JC Eur Neuropsychopharmacol; 2011 Apr; 21(4):333-43. PubMed ID: 20630711 [TBL] [Abstract][Full Text] [Related]
5. Dopamine dysregulation in the prefrontal cortex relates to cognitive deficits in the sub-chronic PCP-model for schizophrenia: A preliminary investigation. McLean SL; Harte MK; Neill JC; Young AM J Psychopharmacol; 2017 Jun; 31(6):660-666. PubMed ID: 28441905 [TBL] [Abstract][Full Text] [Related]
6. Aerobic exercise improves memory and prevents cognitive deficits of relevance to schizophrenia in an animal model. Mitsadali I; Grayson B; Idris NF; Watson L; Burgess M; Neill J J Psychopharmacol; 2020 Jul; 34(7):695-708. PubMed ID: 32431225 [TBL] [Abstract][Full Text] [Related]
7. Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat. Grayson B; Idris NF; Neill JC Behav Brain Res; 2007 Nov; 184(1):31-8. PubMed ID: 17675172 [TBL] [Abstract][Full Text] [Related]
8. Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors reverses sub-chronic PCP-induced deficits in the novel object recognition task in rats. Damgaard T; Larsen DB; Hansen SL; Grayson B; Neill JC; Plath N Behav Brain Res; 2010 Feb; 207(1):144-50. PubMed ID: 19822174 [TBL] [Abstract][Full Text] [Related]
9. Extrasynaptic GABAA receptor activation reverses recognition memory deficits in an animal model of schizophrenia. Damgaard T; Plath N; Neill JC; Hansen SL Psychopharmacology (Berl); 2011 Mar; 214(2):403-13. PubMed ID: 20957350 [TBL] [Abstract][Full Text] [Related]
10. Bacopa monnieri (Brahmi) improved novel object recognition task and increased cerebral vesicular glutamate transporter type 3 in sub-chronic phencyclidine rat model of schizophrenia. Piyabhan P; Wannasiri S; Naowaboot J Clin Exp Pharmacol Physiol; 2016 Dec; 43(12):1234-1242. PubMed ID: 27562725 [TBL] [Abstract][Full Text] [Related]
11. Subchronic PCP effects on DNA methylation and protein expression of NMDA receptor subunit genes in the prefrontal cortex and hippocampus of female rats. Loureiro CM; Fachim HA; Harte MK; Dalton CF; Reynolds GP J Psychopharmacol; 2022 Feb; 36(2):238-244. PubMed ID: 35102781 [TBL] [Abstract][Full Text] [Related]
12. Estradiol attenuates the cognitive deficits in the novel object recognition task induced by sub-chronic phencyclidine in ovariectomized rats. Roseman AS; McGregor C; Thornton JE Behav Brain Res; 2012 Jul; 233(1):105-12. PubMed ID: 22561127 [TBL] [Abstract][Full Text] [Related]
13. Handling prevents and reverses cognitive deficits induced by sub-chronic phencyclidine in a model for schizophrenia in rats. Landreth K; Burgess M; Watson L; Lorusso JM; Grayson B; Harte MK; Neill JC Physiol Behav; 2023 May; 263():114117. PubMed ID: 36781093 [TBL] [Abstract][Full Text] [Related]
14. Chronic infusion of PCP via osmotic mini-pumps: a new rodent model of cognitive deficit in schizophrenia characterized by impaired attentional set-shifting (ID/ED) performance. Pedersen CS; Goetghebeur P; Dias R J Neurosci Methods; 2009 Dec; 185(1):66-9. PubMed ID: 19761795 [TBL] [Abstract][Full Text] [Related]
15. Asenapine improves phencyclidine-induced object recognition deficits in the rat: evidence for engagement of a dopamine D1 receptor mechanism. Snigdha S; Idris N; Grayson B; Shahid M; Neill JC Psychopharmacology (Berl); 2011 Apr; 214(4):843-53. PubMed ID: 21088957 [TBL] [Abstract][Full Text] [Related]
16. The involvement of distraction in memory deficits induced by NMDAR antagonism: relevance to cognitive deficits in schizophrenia. Grayson B; Adamson L; Harte M; Leger M; Marsh S; Piercy C; Neill JC Behav Brain Res; 2014 Jun; 266():188-92. PubMed ID: 24632009 [TBL] [Abstract][Full Text] [Related]
17. Effects of cariprazine, a novel antipsychotic, on cognitive deficit and negative symptoms in a rodent model of schizophrenia symptomatology. Neill JC; Grayson B; Kiss B; Gyertyán I; Ferguson P; Adham N Eur Neuropsychopharmacol; 2016 Jan; 26(1):3-14. PubMed ID: 26655189 [TBL] [Abstract][Full Text] [Related]
18. A preliminary investigation into the effects of antipsychotics on sub-chronic phencyclidine-induced deficits in attentional set-shifting in female rats. McLean SL; Beck JP; Woolley ML; Neill JC Behav Brain Res; 2008 May; 189(1):152-8. PubMed ID: 18282619 [TBL] [Abstract][Full Text] [Related]